CD4 and neoplasm: TIGIT is extensively overexpressed on tumor-infiltrating lymphocytes (TILs) such as CD8+ T cells, CD4+ T cells, regulatory T cells (Tregs), and natural killer (NK) cells across various malignancies [25–31].